(Q42393839)

29 October 2017

0 references

Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key? (English)

1 reference

29 October 2017

Emmanuel S Antonarakis

series ordinal

1

1 reference

29 October 2017

30 December 2014

1 reference

Expert Review of Anticancer Therapy

29 October 2017

1 reference

29 October 2017

15

1 reference

29 October 2017

2

1 reference

29 October 2017

143-145

1 reference

Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Androgen receptor splice variants in the era of enzalutamide and abiraterone

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

An androgen receptor N-terminal domain antagonist for treating prostate cancer.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Increased survival with enzalutamide in prostate cancer after chemotherapy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Abiraterone and increased survival in metastatic prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516117

Molecular states underlying androgen receptor activation: a framework for therapeutics targeting androgen signaling in prostate cancer

28 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25547524

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1586/14737140.2015.999044

1 reference

release_yf7zqgqyhnduflalnehigapala

29 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yf7zqgqyhnduflalnehigapala

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

4516117

1 reference

29 October 2017

1 reference

PMCID

4516117